Clinical Utility of Serum HER2-neu in Monitoring and Prediction of Progression-Free Survival in Metastatic Breast Cancer Patients Treated With Trastuzumab-Based Therapies

HER2-neu serum concentrations measured soon after initiation of trastuzumab-based treatment may be an early predictor of progression-free survival in patients with metastatic breast cancer.

Continue to Clinical Utility of Serum HER2-neu in Monitoring and Prediction of Progression-Free Survival in Metastatic Breast Cancer Patients Treated With Trastuzumab-Based Therapies on Medscape Headlines.

Medical Buzz delivers the most recent headlines from the medical world. Diseases, cures, accidents, medicin. Click below for more headlines ...
Medical buzz